期刊文献+

Ki-67、P27在GCB及non-GCB弥漫性大B细胞淋巴瘤中的表达及意义 被引量:1

Expression and significance of Ki-67 and P27 in germinal centre and non-germinal centre B-like diffuse large B-cell lymphomas
下载PDF
导出
摘要 目的:探讨Ki-67、P27在GCB及non-GCB型弥漫性大B细胞淋巴瘤(DLBCL)中的表达及意义。方法:收集60例DLBCL及19例淋巴结反应性增生组织,并制作其组织芯片,采用免疫组化对DLBCL进行生发中心样B细胞(germinal center B cell-like,GCB)和非生发中心样B细胞(non-GCB)免疫表型分类,同时检测Ki-67及P27蛋白的表达。结果:(1)60例DLBCL中GCB类型29例(48.3%),non-GCB类型31例(51.7%)。(2)Ki-67及P27蛋白的表达在DLBCL中GCB及non-GCB亚型中差异均有显著性意义(均P<0.05)。(3)在DLBCL中Ki-67及P27蛋白表达呈负相关(r=0.449,P<0.05)。结论:Ki-67及P27的表达可能与DLBCL免疫学分型有关,non-GCB中,Ki-67高表达,P27蛋白低表达。 Objectives To investigate the expression and significance of Ki-67 and P27 in germinal centre B-cell like (GCB) and non-germinal centre B-cell like (non-GCB) of the diffuse large B-cell lymphomas (DLBCL). Methods A tissue chip was constructed containing 60 cases of DLBCL and 19 cases of reactive hyperplasia of lymph nodes. The subtype of DLBCL including GCB and non- GCB and the expression of Ki-67 and P27 protein were studied. Results (1) In 60 cases of DLBCL, the type of GCB was 29 cases (48.3%), the type of non-GCB was 31 cases (51.7%). (2) Ki-67 and P27 protein expression were significant difference in GCB and non-GCB subtypes of DLBCL (P 〈 0.05). (3) There were negative correlation between Ki-67 and P27 protein expression in DLBCL.
出处 《实用医学杂志》 CAS 北大核心 2011年第15期2727-2729,共3页 The Journal of Practical Medicine
基金 江西省卫生厅科研基金资助(编号:052017)
关键词 淋巴瘤 大B细胞 弥漫性 KI-67 P27 组织芯片 Lymphoma, large B-Cell, diffuse Ki-67, P27 Tissue chip
  • 相关文献

参考文献8

  • 1张彦宁,周小鸽,张淑红,王鹏,张长淮,黄受方.非霍奇金B细胞淋巴瘤369例病理形态观察 2001年世界卫生组织淋巴组织肿瘤新分类应用体会[J].中华病理学杂志,2005,34(4):193-197. 被引量:36
  • 2Steven H S. WHO Classifcation of tumors of haematopoietic and lymphoid tissues [M]. 4th ed. France: International Agency for Research on Cancer (IARC), 2009 : 234.
  • 3王爱华,沈志祥.弥漫性大B细胞淋巴瘤[M]∥沈志祥,朱雄增.恶性淋巴瘤.北京:人民卫生出版社.2003:503.
  • 4Natkunam Y, Warnke R A, Montgomery K, et al. Analysis of MUMI/IRF4 protoin expression using tissue microarrays and immunhistochemistry [J]. Mod Pathol, 2001,14(7) :686-694.
  • 5Hedvat C V, Hegde A, Chaganti R S, et al. Application of tissue rnicroarray technology to the study of non-Hodgkin's and Hodgkin's lymphoma [J ]. Hum Paol, 2002,33 (10) : 968- 974.
  • 6Pasqualucc L, Neumeister P, Goossens T, et al. Hypermutation of multiple Protoncogenes in B-cell diffuse large cell lymphoma [J]. Nature, 2001,412(6844) :341-346.
  • 7Lloyd R V, Erickson L A, Jin L, et al. p27: a muhifunctional cyclin-dependent kinase inhibit or with prognostic significance in human cancers [J]. Am J Pathol, 1999,154(2):313- 323.
  • 8黎岳南,冯德云,郑晖.非霍奇金淋巴瘤组织中PTEN和p27蛋白的表达[J].湖南医科大学学报,2003,28(3):233-236. 被引量:4

二级参考文献35

  • 1肖畅,苏祖兰,吴秋良,郜红艺,方建晨,夏忠军,管忠震.根据WHO新分类对493例非霍奇金淋巴瘤的临床病理分析[J].中华病理学杂志,2005,34(1):22-27. 被引量:54
  • 2Pennisi E, New tumor supressor found-twice[ J]. Science, 1997,275(5308) : 1876-1878,.
  • 3Li J, Yen C, Liaw D, et al. PTEN, a putative protein tryosine phosphatase gene mutated in human brain, breast, and prostate cancer[ J], Science, 1997, 275 (5308) : 1943-1947.
  • 4Yao YJ, Ping XL, Zhang H, et al. PTEN/MMAC1 mutations in hepatocellular carcinomas[J]. Oncogene, 1999, 18(20) : 3181-3185.
  • 5Kawamura N, Nagai H, Bando K, et al. PTEN/MMACI mutations in hepatocellular carcinomas: somatic inactivation of both alleles in tumors[J]. Jpn J Cancer Res, 1999, 90(4) : 413-418.
  • 6Polyak K, Kato JY, Solomon MJ, et al. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest[J]. Genes Dev, 1994, 8( 1 ) : 9-22.
  • 7An HJ, Shim JY, Kim SJ. Alteration of PTEN expression in endometrial carcinoma is associated with down-regulation of cyclindependent kinase inhibitor, p27 [ J ], Histopathology, 2002,41(5) :437-445.
  • 8Kurose K, Zhou XP, Araki T, et al. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas [ J ]. Am J Pathol, 2001,158 ( 6 ) : 2097-2106.
  • 9Issacson PG, Norton AJ. Extranodal lymphomas [ M ]. Edinburgh: Churchill Livingstone, 1994.5-66.
  • 10Bresalier RS, Ho SB, Schoeppner HL, et al. Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis[J]. Gastroenterology, 1996, 110(5): 1354-1367.

共引文献39

同被引文献13

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部